Site icon OncologyTube

Confirmatory Study Well Supported Across Country | Move PARP-Inhibitors Past BRCA & Breast

Jennifer K. Litton, MD, MD Anderson Cancer Center, talks about Warranting Larger Ongoing Confirmatory Study Possibility of Avoiding Chemo-Therapy in BRCA at Annual Meeting 2018

Exit mobile version